Literature DB >> 29863079

Preparation of Curcumin-Containing α-, β-, and γ-Cyclodextrin/Polyethyleneglycol-Conjugated Gold Multifunctional Nanoparticles and Their in Vitro Cytotoxic Effects on A549 Cells.

Akihiro Hoshikawa1, Mizuki Nagira1, Masafumi Tane1, Kaori Fukushige1, Tatsuaki Tagami1, Tetsuya Ozeki1.   

Abstract

Gold nanoparticles (GNPs) have promising properties such as photothermal effects and could be useful for imaging and as multifunctional nanocarriers for various drugs. In this study, we synthesized polyethyleneglycol (PEG)-grafted GNPs and conjugated them with cyclodextrin (CD) to incorporate curcumin. Curcumin has anticancer effects but its therapeutic application is limited due to poor water solubility. Three types of CDs (α-, β-, and γ-CDs) were conjugated with PEGylated GNPs and the curcumin-containing CD/PEG-conjugated GNPs (cur-CD-GNPs) were characterized. Transmission electron microscopy and dynamic light scattering results showed that these cur-CD-GNPs have a small gold nanocore (approximately 5 nm) and the average size of the three cur-CD-GNPs was approximately 25-35 nm. Curcumin was efficiently incorporated into the β-CD solution and the loading efficiency of curcumin in β-CD-GNPs was the highest of the three types of CD-GNPs prepared. The cytotoxic effect of cur-CD-GNPs was investigated using a human lung cancer cell line. All cur-CD-GNPs exhibited cytotoxic effects comparable to that of curcumin solution and CD-GNPs without curcumin were not cytotoxic. These results suggest that cur-CD-GNPs may be a useful multifunctional nanomedicine, although in vivo investigations are required.

Entities:  

Keywords:  PEGylation; curcumin; cyclodextrin; gold nanoparticle; nanomedicine; poorly-water-soluble drug

Mesh:

Substances:

Year:  2018        PMID: 29863079     DOI: 10.1248/bpb.b18-00010

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  3 in total

1.  Improved solubility and corneal permeation of PEGylated curcumin complex used for the treatment of ophthalmic bacterial infections.

Authors:  Muhammad Hanif; Nabeela Ameer; Qurat-Ul-Ain Ahmad; Mubashir Aziz; Khalid Mahmood; Nasreen Ramzan; Hafiz Muhammad Abdur Rahman
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

Review 2.  Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review.

Authors:  Anandakrishnan Karthic; Arpita Roy; Jaya Lakkakula; Saad Alghamdi; Afnan Shakoori; Ahmad O Babalghith; Talha Bin Emran; Rohit Sharma; Clara Mariana Gonçalves Lima; Bonglee Kim; Moon Nyeo Park; Sher Zaman Safi; Ray Silva de Almeida; Henrique Douglas Melo Coutinho
Journal:  Front Cell Dev Biol       Date:  2022-09-08

Review 3.  Prospects of Curcumin Nanoformulations in Cancer Management.

Authors:  Hilda Amekyeh; Enas Alkhader; Rayan Sabra; Nashiru Billa
Journal:  Molecules       Date:  2022-01-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.